发明名称 |
NUCLEIC ACID MOLECULE SPECIFICALLY BONDING TO PRION PROTEIN |
摘要 |
<P>PROBLEM TO BE SOLVED: To solve the problem of the difficulty in using only an N-terminal 23-89 part as the target of a drug based on the concept that the N-terminal 23-89 part of a normal-type prion protein (PrPc) containing an octa-repeat and supposed to be necessary for the change of the normal-type prion to the abnormal-type prion is rich in glycine and is supposedly impossible to form a stable tertiary structure and the problem to necessitate the use of a whole length prion protein as the target in the case of selecting a molecule specifically bonding to a prion protein and usable for the diagnosis, prevention and treatment of prion disease. <P>SOLUTION: The invention provides a method for the identification and separation of a nucleic acid molecule capable of recognizing a prion protein, a nucleic acid molecule produced by the method, a pharmaceutical composition and diagnostic composition containing the nucleic acid molecule specifically bonding to a prion protein, and a diagnostic method to use the molecule. <P>COPYRIGHT: (C)2006,JPO&NCIPI |
申请公布号 |
JP2006042645(A) |
申请公布日期 |
2006.02.16 |
申请号 |
JP20040226164 |
申请日期 |
2004.08.02 |
申请人 |
NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL & TECHNOLOGY;NATIONAL VETERINARY ASSAY LABORATORY MINISTRY OF AGRICULTURE FORESTRY & FISHERIES |
发明人 |
NISHIKAWA SATOSHI;SEKIYA SATOSHI;PENMECCHA KUMAR;NODA TAKESHI;YOKOYAMA TAKASHI |
分类号 |
C12N15/09;A61K31/7088;A61K31/7105;A61K31/7115;A61P25/00;C07H21/02;C12Q1/68;G01N33/53;G01N33/566 |
主分类号 |
C12N15/09 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|